To assess the severity of COVID-19 in relation toclinical value of immune inflammatory markers: An observational study
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 4, Pages 657-662
Abstract
Background: Since December 2019, an novel type of pneumonia emergedinWuhan,China,and rapidly transmitted to wholeglobe. This pneumonia was verified to
be caused by a different strain coronavirus and named as coronavirus disease
2019(COVID-19) bythe World Health Organization (WHO). Based on
phylogeny,taxonomy and established practice, this novel coronavirus was designated
as severe acute respiratory syndrome coronavirus2 (SARS-COV2).
Objectives: To show the co-relation between inflammatory markers and the severity of
COVID-19 disease
Keywords:
- Article View: 16
- PDF Download: 44